A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors

Summary

This study is an open-label, multicenter Phase I/II clinical trial to evaluate the safety, tolerability, pharmacokinetics and efficacy of SHR-3276 for injection in patients with advanced solid tumors.

Timeline

Start

2024-12-10

Primary completion

2027-12-30

Completion

2028-12-30

Drugs

Indications